NantHealth Stock Price, News & Analysis (NASDAQ:NH)

$3.28 -0.28 (-7.87 %)
(As of 11/20/2017 06:28 AM ET)
Previous Close$3.56
Today's Range$3.26 - $3.61
52-Week Range$2.60 - $13.12
Volume165,700 shs
Average Volume204,836 shs
Market Capitalization$355.32 million
P/E RatioN/A
Dividend YieldN/A
Beta-1.32

About NantHealth (NASDAQ:NH)

NantHealth logoNantHealth, Inc. is a healthcare cloud-based information technology (IT) company. The Company is engaged in converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care. The Company offers the Genomic Proteomic Spectrometry (GPS) Cancer test, a molecular test and decision support solution that measures the proteins present in the patient's tumor tissue, combined with whole genomic and transcriptomic sequencing of tumor and normal samples. The Company also offers Nant Operating System (NantOS) and NantOS applications to healthcare providers and payors, self-insured employers and biopharmaceutical companies. It offers CLINICS, an integrated solution that includes GPS Cancer, NantOS and the NantOS applications. The CLINICS solution includes System Infrastructure, Knowledge Platform, Provider Platform and Payor Platform.


Industry, Sector and Symbol:
  • Industry: Medical Software & Technology Services
  • Sub-Industry: N/A
  • Sector: Medical
  • Symbol: NASDAQ:NH
  • Previous Symbol: NYSE:NH
  • CUSIP: N/A
  • Web: www.nanthealth.com
Debt:
  • Debt-to-Equity Ratio: 0.93%
  • Current Ratio: 2.38%
  • Quick Ratio: 2.36%
Sales & Book Value:
  • Annual Sales: $100.38 million
  • Price / Sales: 3.54
  • Book Value: $3.39 per share
  • Price / Book: 0.97
Profitability:
  • Trailing EPS: ($1.78)
  • Net Income: ($184,100,000.00)
  • Net Margins: -225.76%
  • Return on Equity: -46.09%
  • Return on Assets: -25.23%
Misc:
  • Outstanding Shares: 108,330,000
 

Frequently Asked Questions for NantHealth (NASDAQ:NH)

What is NantHealth's stock symbol?

NantHealth trades on the NASDAQ under the ticker symbol "NH."

How were NantHealth's earnings last quarter?

NantHealth, Inc. (NASDAQ:NH) issued its earnings results on Thursday, November, 9th. The company reported ($0.13) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.14) by $0.01. The company had revenue of $21.76 million for the quarter, compared to analysts' expectations of $29.42 million. NantHealth had a negative net margin of 225.76% and a negative return on equity of 46.09%. The firm's quarterly revenue was up 5.3% on a year-over-year basis. During the same quarter last year, the company posted ($0.18) earnings per share. View NantHealth's Earnings History.

Where is NantHealth's stock going? Where will NantHealth's stock price be in 2017?

4 analysts have issued 1 year price objectives for NantHealth's stock. Their forecasts range from $5.00 to $13.00. On average, they anticipate NantHealth's share price to reach $9.00 in the next twelve months. View Analyst Ratings for NantHealth.

What are Wall Street analysts saying about NantHealth stock?

Here are some recent quotes from research analysts about NantHealth stock:

  • 1. According to Zacks Investment Research, "Nant Health, LLC is a personalized healthcare company which enable improved patient outcomes and treatment decisions for critical illnesses. The company developed an adaptive learning system, CLINICS, which includes its unique software, middleware and hardware systems infrastructure that collects, indexes, analyzes and interprets of molecular, clinical, operational and financial data points derived from novel and traditional sources. Nant Health, LLC is based in CULVER CITY, United States. " (10/25/2017)
  • 2. Cantor Fitzgerald analysts commented, "NantHealth shares are trading lower by about 18% today. The weakness is probably related to a negative article published at StatNews.com. The article claims that Dr. Patrick Soon-Shiong, Nanthealth's CEO, donated $12 million to the University of Utah. In return for the contribution, the article suggests that the University was committed to spend $10 million in "Omics Analysis". As noted above, the company disclosed on its 3Q16 conference call that the company did not recognize revenue related to 180 sequences ordered by the University of Utah. The article also tries to indicate that the company overstated the number of GPS Cancer tests it reported. It claims the orders from the University of Utah were for sequences, not for GPS Cancer tests. While the tests completed were used for preclinical research, the GPS Cancer test is a sequence by definition. Accordingly, we have no problem with the company classifying the Utah orders as GPS Cancer tests given the disclosure and the fact that it did not recognize revenue from the tests." (3/6/2017)

Who are some of NantHealth's key competitors?

Who are NantHealth's key executives?

NantHealth's management team includes the folowing people:

  • Patrick Soon-Shiong M.D., Chairman of the Board, Chief Executive Officer, Founder (Age 64)
  • Paul A. Holt, Chief Financial Officer (Age 50)
  • Michael D. Blaszyk, Independent Director (Age 64)
  • Mark Burnett, Independent Director (Age 56)
  • Kirk K. Calhoun, Independent Director (Age 73)
  • Michael S. Sitrick, Independent Director (Age 69)

When did NantHealth IPO?

(NH) raised $91 million in an IPO on Thursday, June 2nd 2016. The company issued 6,500,000 shares at $12.50-$15.50 per share. Jefferies and Cowen and Company acted as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers.

Who owns NantHealth stock?

NantHealth's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Highbridge Capital Management LLC (0.20%), Emerald Mutual Fund Advisers Trust (0.17%), National Planning Corp (0.11%), Dimensional Fund Advisors LP (0.07%), Bank of New York Mellon Corp (0.05%) and Schwab Charles Investment Management Inc. (0.04%). Company insiders that own NantHealth stock include Healthcare Solution Allscripts, Patrick Soon-Shiong and Ronald Allen Louks. View Institutional Ownership Trends for NantHealth.

Who sold NantHealth stock? Who is selling NantHealth stock?

NantHealth's stock was sold by a variety of institutional investors in the last quarter, including Emerald Mutual Fund Advisers Trust. View Insider Buying and Selling for NantHealth.

Who bought NantHealth stock? Who is buying NantHealth stock?

NantHealth's stock was purchased by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, Schwab Charles Investment Management Inc., National Planning Corp, Bank of New York Mellon Corp and Highbridge Capital Management LLC. Company insiders that have bought NantHealth stock in the last two years include Healthcare Solution Allscripts and Patrick Soon-Shiong. View Insider Buying and Selling for NantHealth.

How do I buy NantHealth stock?

Shares of NantHealth can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is NantHealth's stock price today?

One share of NantHealth stock can currently be purchased for approximately $3.28.

How big of a company is NantHealth?

NantHealth has a market capitalization of $355.32 million and generates $100.38 million in revenue each year. The company earns ($184,100,000.00) in net income (profit) each year or ($1.78) on an earnings per share basis.

How can I contact NantHealth?

NantHealth's mailing address is 9920 JEFFERSON BLVD, CULVER CITY CA, 90232. The company can be reached via phone at 310-883-1300 or via email at [email protected]


MarketBeat Community Rating for NantHealth (NASDAQ NH)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  117 (Vote Outperform)
Underperform Votes:  83 (Vote Underperform)
Total Votes:  200
MarketBeat's community ratings are surveys of what our community members think about NantHealth and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for NantHealth (NASDAQ:NH)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 4 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $9.00 (174.39% upside)

Consensus Price Target History for NantHealth (NASDAQ:NH)

Price Target History for NantHealth (NASDAQ:NH)

Analysts' Ratings History for NantHealth (NASDAQ:NH)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/17/2017Canaccord GenuityLower Price TargetBuy -> Buy$6.00 -> $5.00N/AView Rating Details
9/28/2017Jefferies Group LLCReiterated RatingBuy$5.00LowView Rating Details
4/3/2017Cantor FitzgeraldLower Price TargetOverweight$15.00 -> $13.00HighView Rating Details
4/1/2017FBR & CoSet Price TargetBuy$13.00HighView Rating Details
6/27/2016First AnalysisInitiated CoverageOverweight$18.00N/AView Rating Details
6/27/2016Cowen and CompanyInitiated CoverageOutperform$19.00N/AView Rating Details
(Data available from 11/20/2015 forward)

Earnings

Earnings History and Estimates Chart for NantHealth (NASDAQ:NH)

Earnings by Quarter for NantHealth (NASDAQ:NH)

Earnings History by Quarter for NantHealth (NASDAQ NH)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/9/2017Q3 2017($0.14)($0.13)$29.42 million$21.76 millionViewN/AView Earnings Details
8/10/2017Q2 2017($0.26)($0.58)$31.28 million$26.23 millionViewN/AView Earnings Details
5/10/2017Q1 2017($0.20)($0.24)$29.06 million$22.51 millionViewN/AView Earnings Details
3/30/2017Q4 2016($0.19)($0.18)$30.02 million$24.10 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for NantHealth (NASDAQ:NH)
Current Year EPS Consensus Estimate: $-1.44 EPS
Next Year EPS Consensus Estimate: $-0.78 EPS

Dividends

Dividend History for NantHealth (NASDAQ:NH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for NantHealth (NASDAQ NH)

Institutional Ownership Percentage: 6.09%
Insider Trades by Quarter for NantHealth (NASDAQ:NH)
Insider Trades by Quarter for NantHealth (NASDAQ:NH)

Insider Trades by Quarter for NantHealth (NASDAQ NH)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/6/2017Ronald Allen LouksCOOSell6,705$3.39$22,729.95View SEC Filing  
10/6/2017Ronald Allen LouksCOOSell26,820$4.28$114,789.60View SEC Filing  
6/7/2016Healthcare Solution AllscriptsMajor ShareholderBuy714,286$14.00$10,000,004.00View SEC Filing  
6/7/2016Patrick Soon-ShiongCEOBuy357,143$14.00$5,000,002.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for NantHealth (NASDAQ NH)

Source:
DateHeadline
NantHealth (NH) versus Its Peers Head to Head AnalysisNantHealth (NH) versus Its Peers Head to Head Analysis
www.americanbankingnews.com - November 19 at 5:06 PM
Head-To-Head Survey: NantHealth (NH) & Medical Transcription Billing, Corp. (MTBC)Head-To-Head Survey: NantHealth (NH) & Medical Transcription Billing, Corp. (MTBC)
www.americanbankingnews.com - November 19 at 3:24 AM
NantHealth Ranked Number 304 Fastest Growing Company in North America on Deloitte’s 2017 Technology Fast 500™NantHealth Ranked Number 304 Fastest Growing Company in North America on Deloitte’s 2017 Technology Fast 500™
finance.yahoo.com - November 18 at 7:48 AM
NantHealth, Inc. (NH) Given New $5.00 Price Target at Canaccord GenuityNantHealth, Inc. (NH) Given New $5.00 Price Target at Canaccord Genuity
www.americanbankingnews.com - November 17 at 7:12 PM
Cotiviti Holdings (COTV) vs. NantHealth (NH) Head-To-Head ContrastCotiviti Holdings (COTV) vs. NantHealth (NH) Head-To-Head Contrast
www.americanbankingnews.com - November 17 at 5:06 PM
NH Food Bank planning to distribute 18,000 turkeys this ThanksgivingNH Food Bank planning to distribute 18,000 turkeys this Thanksgiving
www.msn.com - November 14 at 3:07 AM
NH statehouse combat veterans discuss state of veterans servicesNH statehouse combat veterans discuss state of veterans services
www.msn.com - November 13 at 8:52 AM
Many happy to see snow in northern NHMany happy to see snow in northern NH
www.msn.com - November 12 at 10:55 AM
Ohio line workers help restore power to NH residentsOhio line workers help restore power to NH residents
www.msn.com - November 4 at 8:46 PM
Gun Charge Dropped Against NH Mother, But Damage To Reputation RemainsGun Charge Dropped Against NH Mother, But Damage To Reputation Remains
www.msn.com - November 4 at 4:55 AM
NantHealth to Report 2017 Third-Quarter Financial Results and Host Conference Call on Thursday, November 9NantHealth to Report 2017 Third-Quarter Financial Results and Host Conference Call on Thursday, November 9
finance.yahoo.com - November 3 at 1:48 PM
ETFs with exposure to NantHealth, Inc. : November 3, 2017ETFs with exposure to NantHealth, Inc. : November 3, 2017
finance.yahoo.com - November 3 at 1:48 PM
Manhattan Beach teen dies after skateboard skitching trick goes wrongManhattan Beach teen dies after skateboard 'skitching' trick goes wrong
www.latimes.com - April 11 at 10:59 AM
Kansas Democrats Are About To Show Just How Big The Anti-Trump Wave Actually IsKansas Democrats Are About To Show Just How Big The Anti-Trump Wave Actually Is
www.huffingtonpost.com - April 11 at 10:59 AM
Joy Villa: Life has changed for the better since pro-Trump Grammys dressJoy Villa: Life has changed for the better since pro-Trump Grammys dress
www.foxnews.com - April 10 at 10:11 AM
5 children injured after bounce house goes airborne at South Carolina carnival5 children injured after bounce house goes airborne at South Carolina carnival
www.foxnews.com - April 9 at 9:46 AM
Experts Say Susan Rice Had Every Right To Request ‘Unmasking’ In Intel ReportsExperts Say Susan Rice Had Every Right To Request ‘Unmasking’ In Intel Reports
www.msn.com - April 3 at 11:11 PM
Kentucky’s Last Abortion Clinic Saved From ‘Imminent Closure’Kentucky’s Last Abortion Clinic Saved From ‘Imminent Closure’
www.nbcnews.com - March 31 at 6:56 PM
Professor tweets trying not to vomit after passenger gives up seat to soldierProfessor tweets 'trying not to vomit' after passenger gives up seat to soldier
www.usatoday.com - March 31 at 9:20 AM
Heres proof robots are taking jobs and cutting wagesHere's proof robots are taking jobs and cutting wages
www.foxnews.com - March 29 at 7:26 PM
House Votes in Favor of Letting ISPs Sell Your Browsing HistoryHouse Votes in Favor of Letting ISPs Sell Your Browsing History
www.nbcnews.com - March 28 at 6:37 PM
Kushner to Appear Before Senate Intel Committee on RussiaKushner to Appear Before Senate Intel Committee on Russia
www.nbcnews.com - March 27 at 10:08 AM
NantHealth and Dr. Soon-Shiong Send Letters to Statnews.com Listing Errors and Corresponding FactsNantHealth and Dr. Soon-Shiong Send Letters to Statnews.com Listing Errors and Corresponding Facts
us.rd.yahoo.com - March 16 at 7:32 PM
NantHealth Inc. (NH) Sank To A New Low On Reports Of InvestigationNantHealth Inc. (NH) Sank To A New Low On Reports Of Investigation
www.rttnews.com - March 7 at 10:08 AM
Cantor Fitzgerald Starts NantHealth (NH) at OverweightCantor Fitzgerald Starts NantHealth (NH) at Overweight
www.streetinsider.com - January 5 at 8:27 PM
NantHealth to Raise Up $120 Mln in Notes OfferingNantHealth to Raise Up $120 Mln in Notes Offering
www.nasdaq.com - December 15 at 7:44 PM
NantHealth Continues Global Expansion Of GPS Cancer™ By Bringing Advanced Molecular Profiling to Patients in the Middle East Through Partnership with LunatusNantHealth Continues Global Expansion Of GPS Cancer™ By Bringing Advanced Molecular Profiling to Patients in the Middle East Through Partnership with Lunatus
us.rd.yahoo.com - December 5 at 6:51 PM
10:06 am Nant Health enters into an exclusive reseller agreement for GPS Cancer advanced molecular analysis with Lunatus in the Middle East10:06 am Nant Health enters into an exclusive reseller agreement for GPS Cancer advanced molecular analysis with Lunatus in the Middle East
us.rd.yahoo.com - December 5 at 6:51 PM
NANTHEALTH, INC. Files SEC form 10-Q, Quarterly ReportNANTHEALTH, INC. Files SEC form 10-Q, Quarterly Report
biz.yahoo.com - November 10 at 6:12 PM
NANTHEALTH, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsNANTHEALTH, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
biz.yahoo.com - November 7 at 7:03 PM
NantHealth Inc Earnings Call scheduled for 6:00 pm ET todayNantHealth Inc Earnings Call scheduled for 6:00 pm ET today
biz.yahoo.com - November 7 at 7:03 PM
NantHealth Announces Global Expansion of GPS Cancer; Partners with Sorgente to Expand Availability of GPS Cancer™ to ItalyNantHealth Announces Global Expansion of GPS Cancer; Partners with Sorgente to Expand Availability of GPS Cancer™ to Italy
www.businesswire.com - November 3 at 10:24 AM
Cancer MoonShot 2020 Milestone: Announcing Launch Of The Nations Largest Pediatric Brain Tumor AtlasCancer MoonShot 2020 Milestone: Announcing Launch Of The Nation's Largest Pediatric Brain Tumor Atlas
www.thestreet.com - October 28 at 6:12 PM
NantHealth Announces Immunotherapy Clinical...NantHealth Announces Immunotherapy Clinical...
www.benzinga.com - October 26 at 6:28 PM
NantHealth Announces Immunotherapy Clinical Trials in the Mid-Atlantic, First Whole Genomics Supercomputing Medical Reasoning Engine Helps Oncologists Make Informed Treatment ...NantHealth Announces Immunotherapy Clinical Trials in the Mid-Atlantic, First Whole Genomics Supercomputing Medical Reasoning Engine Helps Oncologists Make Informed Treatment ...
www.businesswire.com - October 26 at 6:28 PM
NANT HEALTH, LLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsNANT HEALTH, LLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
biz.yahoo.com - August 9 at 6:42 PM
NantHealth Inc Earnings Call scheduled for 5:00 pm ET todayNantHealth Inc Earnings Call scheduled for 5:00 pm ET today
biz.yahoo.com - August 9 at 6:42 PM

Social Media

Financials

Chart

NantHealth (NASDAQ NH) Chart for Monday, November, 20, 2017
Loading chart…

This page was last updated on 11/20/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.